- Home
- LYTS vs KROS Comparison
LYTS vs KROS Comparison
Compare LYTS & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYTS
- KROS
- Stock Information
- Founded
- LYTS 1976
- KROS 2015
- Country
- LYTS United States
- KROS United States
- Employees
- LYTS N/A
- KROS N/A
- Industry
- LYTS Building Products
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- LYTS Consumer Discretionary
- KROS Health Care
- Exchange
- LYTS Nasdaq
- KROS Nasdaq
- Market Cap
- LYTS 549.1M
- KROS 565.0M
- IPO Year
- LYTS N/A
- KROS 2020
- Fundamental
- Price
- LYTS $23.29
- KROS $15.59
- Analyst Decision
- LYTS Strong Buy
- KROS Buy
- Analyst Count
- LYTS 2
- KROS 14
- Target Price
- LYTS $27.50
- KROS $20.56
- AVG Volume (30 Days)
- LYTS 216.0K
- KROS 487.1K
- Earning Date
- LYTS 11-06-2025
- KROS 11-05-2025
- Dividend Yield
- LYTS 0.86%
- KROS N/A
- EPS Growth
- LYTS N/A
- KROS N/A
- EPS
- LYTS 0.79
- KROS 0.47
- Revenue
- LYTS $573,377,000.00
- KROS $232,844,000.00
- Revenue This Year
- LYTS $6.88
- KROS $5,579.44
- Revenue Next Year
- LYTS $6.95
- KROS N/A
- P/E Ratio
- LYTS $29.48
- KROS $33.50
- Revenue Growth
- LYTS 22.09
- KROS 85820.30
- 52 Week Low
- LYTS $13.77
- KROS $9.12
- 52 Week High
- LYTS $25.50
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- LYTS 71.68
- KROS 60.26
- Support Level
- LYTS $21.90
- KROS $15.38
- Resistance Level
- LYTS $23.16
- KROS $16.07
- Average True Range (ATR)
- LYTS 1.02
- KROS 0.66
- MACD
- LYTS 0.13
- KROS 0.08
- Stochastic Oscillator
- LYTS 90.69
- KROS 76.54
About LYTS LSI Industries Inc.
LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays and custom display elements.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.